Bio-Rad Laboratories (BIO) Short-term Investments (2009 - 2026)

Bio-Rad Laboratories (BIO) has 18 years of Short-term Investments data on file, last reported at $1.1 billion in Q1 2026.

• On a quarterly basis, Short-term Investments fell 7.16% year-over-year to $1.1 billion in Q1 2026; TTM through Mar 2026 was $1.1 billion, a 7.16% decrease from a year earlier, with the FY2025 full-year figure at $1.0 billion, down 14.07% from the prior year.
• Short-term Investments for Q1 2026 stood at $1.1 billion, up from $1.0 billion in the prior quarter.
• Over the last five years, Short-term Investments for BIO reached as high as $1.4 billion in Q2 2022 and fell as low as $5.6 million in Q1 2022.
• Historically, Short-term Investments has averaged $914.3 million across 5 years, with a median of $1.1 billion in 2025.
• Across the five-year window, Short-term Investments soared 24122.45% in 2022 and slumped 99.58% in 2024, its largest moves.
• Year by year, Short-term Investments stood at $1.4 billion in 2022, then slipped by 11.29% to $1.2 billion in 2023, then declined by 2.24% to $1.2 billion in 2024, then dropped by 14.07% to $1.0 billion in 2025, then increased by 4.61% to $1.1 billion in 2026.
• Per Business Quant data, the three most recent Short-term Investments figures were $1.1 billion in Q1 2026, $1.0 billion in Q4 2025, and $1.0 billion in Q3 2025.